New hip implant aims for longer life, fewer surgeries

NCT ID NCT04325022

Ongoing Disease control Sponsor: Smith & Nephew, Inc. Source: ClinicalTrials.gov ↗

Summary

This study is testing the safety and long-term performance of a new type of hip replacement system called OR3O™. It involves 177 adults with severe hip joint damage or those needing a replacement for a previous failed hip replacement. Researchers will follow patients for up to 10 years to see how well the implant holds up and improves pain, mobility, and quality of life.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Locations

Calvary John James Hospital

Deakin, 2600, Australia
Hospital for Special Surgery

New York, New York, 10021, United States
Mater Health Services

Brisbane, Queensland, 4101, Australia
NYU Langone Health

New York, New York, 10003, United States
Queen Mary Hospital

Hong Kong, 2255, Hong Kong
Royal Perth Hospital

Perth, Western Australia, 6000, Australia
South Health Campus, Calgary

Calgary, Alberta, T3M127, Canada
St Michael's Hospital

Toronto, Ontario, M5C1R6, Canada
St. David's Center for Hip and Knee Replacement

Austin, Texas, 78705, United States
University of Kentucky

Lexington, Kentucky, 40508, United States
University of Nebraska Medical Center

Omaha, Nebraska, 69198, United States
Wake Forest School of Medicine

Winston-Salem, North Carolina, 27157, United States

Conditions

Explore the condition pages connected to this study.

ADVANCED DEGENERATION OF THE HIP JOINT REVISION OF THE HIP JOINT